In Brief: Flu vaccine '95-'96
Executive Summary
Flu vaccine '95-'96: Should incorporate an A(H3N2) component of a Johannesberg/33/94-like strain and a B component of a Beijing/184/93-like strain, FDA's Vaccines & Related Biologics Advisory Committee recommends March 17. The committee already had recommended an A(H1N1) Texas/36/91-like strain as the third component at its January meeting ("The Pink Sheet" Jan. 30, T&G-2). The strains selected are consistent with those chosen by the World Health Organization Feb. 17, the committee says..